Global Conjugate Vaccines Market (2019 - 2027)

The market for conjugate vaccines is expected to increase, owing to global awareness about the benefits of vaccination for the prevention of certain life-threatening diseases, growing initiatives for production of low-cost vaccines, and widespread routine vaccination programmes in emerging economies. The market will witness a steady growth, expanding at a compound annual growth rate (CAGR) of 11.7% during 2017-2022, to reach approximately USD 87.7 Bn by 2022.
Disease indication segment insights:
Pneumococcal conjugate vaccine (PCV) held the largest market share (24.66%) in 2017 owing to the widespread nature of pneumococcal disease. Also, the leading vaccine-preventable cause of death among children around the world is the pneumococcal disease. Global initiatives were undertaken to speed up the introduction of pneumococcal vaccinations in low-income countries through partnerships among countries, donors, academia, international organizations, and industries. Close on its heels, the diphtheria and tetanus toxoids and pertussis (DTP) conjugate vaccine occupied a share of 23% in 2017. The higher prevalence of respiratory diseases such as whooping cough, among both children and adults, have led to the increased adoption of DTP conjugate vaccines. Haemophilus influenzae type b (Hib) conjugate vaccines are expected to grow at the fastest rate during 2017-2022.
End user segment insights:
The adult segment registered higher market share than the paediatric segment because of an increase in awareness on conjugate vaccines for adults, over the years. Still, the penetration level for adult conjugate vaccines is comparatively lower, with the lowest being for PCVs. Hence, the growth potential is very high. The paediatric vaccines, on the other hand is a stable market and depends highly on the birth rates in each region. The vaccination programmes, especially taken up by global organizations such as the United Nations Educational, Scientific and Cultural Organization (UNESCO), have been successful in eradicating many such vaccine-preventable diseases.
Regional insights:
Asia-Pacific is the largest market for conjugate vaccines, which held a share of 42%, in 2017. The primary indicators of the potential for the vaccine market is the geriatric population in the region, especially in countries such as India and China. In turn, this has, encouraged market participants to increase spending on research and development (R&D) and distribution facilities in the these countries. North America is the second biggest market for conjugate vaccines, owing to the region's widespread immunization programmes. The Middle East and Africa, and Latin America regions lack proper infrastructure and awareness of vaccine-preventable diseases, which are hindering market growth.


Companies covered:
1. GlaxoSmithKline
2. Pfizer Inc.
3. Merck & Co.
4. Novartis
5. Sanofi Pasteur
6. CSL Limited
7. Bharat Biotech International
8. Biological E Limited
9. Serum Institute of India

Customizations available
With the given market data, Netscribes offers customizations according to specific needs. Write to us at [email protected], or connect with us here.
Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2. Global conjugate vaccine market - overview

2.1. Market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
2.2. Market drivers
2.3. Market trends
2.4. Market challenges
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Segmentation based on disease indication (pneumococcal conugate vaccine (PCV), haemophilus influenzae type B (Hib) conjugate vaccine, diptheria, tetanus toxoids and pertussis (DTP) conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
2.8. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 3. North America conjugate vaccine market

3.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
3.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
3.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 4. Europe conjugate vaccine market

4.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
4.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
4.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 5. Asia-Pacific conjugate vaccine market

5.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
5.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
5.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 6. Latin America conjugate vaccine market

6.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
6.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
6.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 7. The Middle East and Africa conjugate vaccine market

7.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
7.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
7.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 8. Competitive landscape

8.1. GlaxoSmithKline
8.1.a. Company snapshot
8.1.b. Products/services
8.1.c. Major initiatives/highlights
8.1.d. Growth strategy
8.1.e. Geographical presence
8.1.f. Key numbers
Note: Similar information areas will be covered for the remaining competitors:
8.2. Pfizer Inc.
8.3. Merck & Co.
8.4. Novartis
8.5. Sanofi Pasteur
8.6. CSL Limited
8.7. Bharat Biotech International
8.8. Biological E Limited
8.9. Serum Institute of India

Chapter 9. Conclusion
9.1. Future outlook

Appendix
1. List of tables
2. Research methodology
3. Assumptions
4. About Netscribes Inc.

Global Anthrax Vaccines Market Analysis 2015-2019 and Forecast 2020-2025

Published Date : Jan 2020

Snapshot Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides. The global Anthrax Vaccines market size is estimated at xxx million USD with...

Global Foot and Mouth Disease (FMD) Vaccines Market Analysis 2015-2019 and Forecast 2020-2025

Published Date : Jan 2020

Snapshot The global Foot and Mouth Disease (FMD) Vaccines market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes in...

Global Bovine Vaccines Market Research (2015-2019) and Future Forecast (2020-2025)

Published Date : Jan 2020

Summary The report forecast global Bovine Vaccines market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Bovine Vaccines industry and main market trends. The market research includes historical and forecast ...

Global Oral Vaccines Market Research (2015-2019) and Future Forecast (2020-2025)

Published Date : Jan 2020

Summary The report forecast global Oral Vaccines market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Oral Vaccines industry and main market trends. The market research includes historical and forecast mark...

Global Foot and Mouth Disease (FMD) Vaccines Market Research (2015-2019) and Future Forecast (2020-2025)

Published Date : Jan 2020

Summary The report forecast global Foot and Mouth Disease (FMD) Vaccines market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Foot and Mouth Disease (FMD) Vaccines industry and main market trends. The marke...

Global Chicken Vaccines Market Research (2015-2019) and Future Forecast (2020-2025)

Published Date : Dec 2019

Summary The report forecast global Chicken Vaccines market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Chicken Vaccines industry and main market trends. The market research includes historical and forecas...

Global mRNA Vaccines & Therapeutics Market Research (2015-2019) and Future Forecast (2020-2025)

Published Date : Dec 2019

Summary The report forecast global mRNA Vaccines & Therapeutics market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of mRNA Vaccines & Therapeutics industry and main market trends. The market research include...

Global Poultry Vaccines Market Research Report 2020-2024

Published Date : Jan 2020

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Poultry Vaccines Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regiona...

Global Aujeszky Disease Vaccines Market Research Report 2020-2024

Published Date : Jan 2020

Aujeszky's disease (AD) vaccination has pioneered novel strategies in animal disease control by the first use of marker vaccines. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Aujeszky Disease Vaccines Report by Mate...

Global Porcine Epidemic Diarrhea Vaccines Market Research (2015-2019) and Future Forecast (2020-2025)

Published Date : Dec 2019

Summary The report forecast global Porcine Epidemic Diarrhea Vaccines market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Porcine Epidemic Diarrhea Vaccines industry and main market trends. The market rese...

 

Select License :

  • Single User : $2950

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.